Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
DeFi Technologies Subsidiary Valour Introduces World’s first Physical Yield Bearing Bitcoin (1VBS) ETP in Collaboration with Core Foundation, to German Investors on Xetra, Offering Exposure to Bitco
-
Update on FDA Review of VTAMA® (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older
-
Purpose Investments Unveils New Meta and AMD Single-Stock Yield Shares ETFs in Its Acclaimed Yield Shares Suite
-
Terms for Nykredit's and Totalkredit's auctions - Nykredit Realkredit A/S
-
Snipp Interactive Reports Preliminary Financial Results for Q3 2024
-
Bionoid Pharma, Inc. Unveils Five-Year Strategic Roadmap
-
MIND CTI Reports Third Quarter 2024 Results
-
AdaptHealth Corp. Announces Third Quarter 2024 Results
-
From NYC to the ABCs: JetBlue Begins More Caribbean Service with Flights to Bonaire
-
A New Era in DeFi: OptSwap Launches Innovative Crypto Options Trading Platform
-
Long Time Wall Street Professional - Mark Martini, former Bear Stearns, Bank of America and Deutsche Banker and Broker, Launches WimbledonGlobal
-
HUB Security Announces Strategic Initiatives and Upcoming Financial Results Amid U.S. Market Penetration Plans
-
GRASS, a DePIN Project, Will Be Initially Listed on CoinW Exchange
-
Invesco Ltd: Form 8.3 - Anglogold Ashanti PLC; Public dealing disclosure
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
Core Scientific Announces October 2024 Production and Operations Updates
-
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
-
From Contract to Space in Less Than Ten Weeks: Rocket Lab Launches its 54th Electron Mission
-
EUMETSAT: Lisbon Event Offers a Deep Dive Into Ocean Data
-
PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer
-
uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress
-
Apellis Pharmaceuticals Reports Third Quarter 2024 Financial Results
-
TransAlta Reports Strong Third Quarter 2024 Results
-
Events make the voices of global youth better heard
-
Scirovepet Launches New Stainless Steel Cat Litter Box, Reinforcing Commitment to Pet Safety and Health
-
Sonim H500 5G Mobile Hotspot Now Available at Verizon Wireless
-
Interactive Strength Inc. To Announce Third Quarter 2024 Results on Nov. 14, 2024
-
Orbec Closes First Tranche of Upsized Placement
-
Electrovaya to Attend Two Investor Conferences
-
North Valley Receives 100 Drill Hole Permit For Its Comstock Property; Provides Exploration and Company Updates
-
Plurilock Security Achieves CMMC Level 1 Compliance for the United States Department of Defense
-
Gogo Announces Third Quarter Results
-
Find your next adventure with the rugged Tread 2 powersports navigator from Garmin
-
Xometry Reports Third Quarter 2024 Results
-
700Credit Industry Survey Shows the Alarming Lack Of Procedure RV Dealers Still Have In Collecting Drivers’ Licenses For Test Drives & High Susceptibility To Multiple Types Of Fraud
-
700Credit Industry Survey Shows the Alarming Lack Of Procedure RV Dealers Still Have In Collecting Drivers’ Licenses For Test Drives & High Susceptibility To Multiple Types Of Fraud
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Gate.io Shatters Records in Total Trading Volume in Q3 2024, with Its User Base Surpassing 17 Million
-
SpringWorks Therapeutics to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
-
Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights
-
Colliers Reports Third Quarter Results
-
RNAConnect Launches the UltraMarathonRT® RT-PCR Kit at ASHG 2024
-
The Global Wellness Economy Reaches a New Peak of $6.3 Trillion--And Is Forecast to Hit $9 Trillion by 2028
-
Sotera Health Reports Third-Quarter and Year-to-Date 2024 Results
-
Aura Minerals and Bluestone Resources Agree to Amendment to Arrangement Agreement
-
R1 RCM Reports Third Quarter 2024 Results
-
OGE Energy Corp. reports third quarter 2024 results
-
Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia
-
Beasley Broadcast Group Reports Third Quarter Revenue of $58.2 Million
-
Zepp Health Corporation to Report Third Quarter 2024 Financial Results on November 18, 2024

